Published in:
01-08-2009 | Commentary
Challenging the rationale of routine vasopressor therapy for management of hypotension
Authors:
Max Harry Weil, Wanchun Tang
Published in:
Critical Care
|
Issue 4/2009
Login to get access
Abstract
There is persuasive evidence, including the present report by Dubin and colleagues, of a dissociation between increases in arterial pressure produced by vasopressor agents and improvement in microvascular perfusion and delivery of vital substrates. Especially in settings of septic shock, the current routine administration of adrenergic vasopressor therapy therefore may fail to reverse the primary defect.